Merck
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $16,657,000 | $16,156,000 | $15,775,000 | $14,630,000 |
Gross Profit | 12,577,000 | 11,863,000 | 12,235,000 | 11,290,000 |
EBITDA | 5,606,000 | 7,380,000 | 6,744,000 | 679,000 |
EBIT | 4,420,000 | 6,316,000 | 5,760,000 | -299,000 |
Net Income | 3,157,000 | 5,455,000 | 4,762,000 | -1,226,000 |
Net Change In Cash | 16,657,000 | 16,156,000 | 15,775,000 | 14,630,000 |
Free Cash Flow | 8,508,000 | 4,846,000 | 2,229,000 | -743,000 |
Cash | 14,593,000 | 11,346,000 | 5,579,000 | 6,909,000 |
Basic Shares | 2,541,000 | 2,544,000 | 2,532,700 | 2,533,000 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $60,115,000 | $59,283,000 | $48,704,000 | $41,518,000 |
Gross Profit | 43,989,000 | 41,872,000 | 35,078,000 | 27,900,000 |
EBITDA | 6,907,000 | 21,315,000 | 17,899,000 | 10,180,000 |
EBIT | 3,035,000 | 17,406,000 | 14,685,000 | 6,694,000 |
Net Income | 365,000 | 14,519,000 | 13,049,000 | 7,067,000 |
Net Change In Cash | 60,115,000 | 59,283,000 | 48,704,000 | 41,518,000 |
Cost of Revenue | 5,016,000 | -202,000 | -2,022,000 | |
Free Cash Flow | 9,143,000 | 14,707,000 | 9,661,000 | 5,569,000 |
Cash | 6,841,000 | 12,694,000 | 8,096,000 | 8,062,000 |
Basic Shares | 2,547,000 | 2,542,000 | 2,538,000 | 2,541,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.57 |
2024-06-30 | $2.28 |
2024-03-31 | $2.07 |
2023-12-31 | $0.03 |
